Aiforia Technologies Plc announced the release of Aiforia® Studies, a software module that offers AI-assisted image analysis workflow within the framework of Good Laboratory Practices (GLP). Aiforia® Studies is designed especially for pharmaceutical companies and contract research organizations engaged in non-clinical histology studies that need to adhere to GLP guidelines, although its application is not restricted to such studies.
Market Closed -
Other stock markets
|
After market 03:06:29 pm | |||
3.95 EUR | 0.00% | 3.895 | -1.39% |
May. 15 | Aiforia Wins a Framework Agreement to Provide AI Solutions for Fimlab Laboratories in Finland | CI |
Apr. 24 | Aiforia Signs A Contract with A Veterinary Health Company in the US | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.18% | 111M | |
+13.54% | 3,200B | |
+14.20% | 87.43B | |
+8.40% | 79.69B | |
-11.45% | 56.79B | |
+20.65% | 47.14B | |
+29.20% | 46.62B | |
-27.04% | 45.5B | |
+76.04% | 42.31B | |
-5.30% | 25.81B |
- Stock Market
- Equities
- AIFORIA Stock
- News Aiforia Technologies Oyj
- Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow